Legend Biotech (LEGN) is down -10.8%, or -$3.05 to $25.08.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LEGN:
- Legend Biotech Unveils Promising CARVYKTI® Data at ASH 2025
- Legend Biotech price target lowered to $48 from $54 at UBS
- Legend Biotech highlights new CARVYKTI data in RRMM
- H.C. Wainwright says Legend Biotech competition concerns overdone
- Buy Rating for Legend Biotech Reaffirmed Due to CARVYKTI’s Strong Market Position and Proven Efficacy